DOI: https://doi.org/10.36347/sjams.2026.v14i02.021

Pages: 264-268

Background: T-Y-Intercondylar fractures (AO Type-13C1 & 13C2) of the distal humerus are complex intra-articular injuries that pose significant challenges in achieving stable fixation and optimal functional recovery. The principle is anatomical reduction and rigid fixation. Anatomical reconstruction plating and double tension band wiring are commonly employed techniques, each with distinct biomechanical, clinical and socioeconomical implications. Objective: To compare Double Anatomical Plating (Group I) and Tension Band Wiring (TBW) (Group II) in the management of T-Y Intercondylar distal humerus fractures AO type 13C1 & 13C2 in respect to pain, elbow range of motion (ROM), mayo elbow performance score (MEPS), functional outcomes, cost benefit ratio and postoperative recovery. Method: A prospective, randomized comparative study was conducted at a tertiary orthopedic center Khulna Medical College Hospital in Khulna, Bangladesh, from January 2024 to March 2025. Twenty-four adult patients with closed, fresh bicondylar intra-articular distal humerus fractures AO Type 13C1 & 13C2 were randomized into two groups: Group I (n = 12) underwent open reduction and internal fixation with Double Anatomical Plates and screws, while Group II (n = 12) received Tension Band Wiring (TBW). Clinical assessment, pain scoring, range of motion (ROM) evaluation, Mayo Elbow Performance Score (MEPS) and functional outcomes were recorded and analyzed using SPSS version 15, with p < 0.05 considered statistically significant. Results: The majority of patients in both groups were aged 18–30 years (Group I: 58.33%, Group II: 54.17%), with a slight female predominance in Group II (58.33%). AO type 13C2 fractures were more frequent (Group I: 66.67%, Group II: 75.00%). Postoperative assessment showed that no pain was reported more frequently in Group I (33.33%) than Group II (25.00%), and loss of elbow motion beyond functional margin was lower in Group I (8.33%) compared to Group II (25.00%). Excellen